Restricted accessResearch articleFirst published 2026-03-01pp. 279-288Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis Luca BolloORCID, Deborah ParetoORCID, Paula TaglianiORCID , [...]View all
Restricted accessResearch articleFirst published 2026-03-01pp. 268-278Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)—A meta-regression of randomized controlled trials Roxanne PretzschORCID, Sahla El MahdaouiORCID, Poljanka JohnsonORCID , [...]View all
Restricted accessResearch articleFirst published 2026-03-01pp. 263-264Patient voice: The label given to my MS disease course matters to me—Yes Jon Strum
Restricted accessResearch articleFirst published 2026-03-01pp. 315-325Availability and affordability of therapies and services of multiple sclerosis in Africa: A continent-wide survey Ali ShalashORCID, Daniel Gams MassiORCID, Samia Ben SassiORCID , [...]View all